Current Neuro-Oncology
Volume
27 Number 32
20 November 2025
Home > Publications > Current Neuro-Oncology > Volume 27, Year 2025 > Number 32, 20 November
Laaidi A, Jamal O, Jehri AEH, Makhchoune M, Karkouri M, Ibahioin
K, Hilmani S, Naja A, Lakhdar A.
Diffuse
Low-Grade Glioma With Spontaneous Radiological Regression: A Case
to Be Followed.
Cureus.
2025 Nov 12;17(11):e96671. doi:
10.7759/cureus.96671. PMID:
41393573. Case report. ˍ
Wu CC, Szalontay L, Pouliopoulos AN, Bae S, Berg X, Wei HJ,
Webster Carrion A, Kokossis D, Sethi C, Fino J, Shatravka H,
Lipina J, Ji R, Liu K, Yousefian O, Gallitto M, Yoh N, Englander
Z, McQuillan N, Tazhibi M, De Los Santos G, Canoll P, Jin Z,
Garvin J, Gartrell RD, Pavisic J, Maddocks A, Lignelli A,
Feldstein N, Konofagou EE, Zacharoulis S.
Blood-brain
barrier opening with neuronavigation-guided focused ultrasound in
pediatric patients with diffuse midline glioma.
Sci
Transl Med. 2025 Nov 12;17(824):eadq6645. doi:
10.1126/scitranslmed.adq6645. PMID:
41223245. Interventional study. ˍ
Lenga P, Scherer M, Dao Trong P, Krieg SM, Suchorska B.
Sex-specific disparities in
postoperative adverse events following intracranial tumor surgery:
insights from a tertiary neurosurgical center.
Acta
Neurochir (Wien). 2025 Nov 13;167(1):292. doi:
10.1007/s00701-025-06708-z. PMID:
41231356. Observational study. ˍ
Truusalu JP, Oselin K, Lass J, Buck KK, Sietsema W, Soeorg H,
Toome K, Kaarna K, Teesalu T, Kõrgvee LT.
LSTA1-GBM-2A:
study protocol for an exploratory phase 2a randomised controlled
trial evaluating tumour-homing peptide certepetide with
temozolomide in glioblastoma multiforme.
BMJ
Open. 2025 Nov 13;15(11):e106094. doi:
10.1136/bmjopen-2025-106094. PMID:
41248393. Interventional study protocol. ˍ
Zeyen T, Krause I, Decker A, Kroh F, Regnery S, Weller J, Schaefer
N, Zidan M, Potthoff AL, Schneider M, Friker LL, Keupp J, Katemann
C, Layer JP, Schaub C, Gkika E, Vatter H, Pietsch T, Radbruch A,
Herrlinger U, Paech D.
Amide proton
transfer-weighted (APTw) CEST MRI in clinical routine for single
time point diagnosis of pseudoprogression in IDH-wildtype
glioblastoma.
Neuro
Oncol. 2025 Nov 13:noaf261. doi:
10.1093/neuonc/noaf261. PMID:
41233976. Observational study. ˍ
Lohela J, Lehtiö K, Inget K, Karhula SS, Piironen S, Suutari
A, Knuutinen A, Jänkälä M, Lammentausta E, Bode MK,
Nikkinen J, Salokorpi N, Keinänen T.
Improved
brain tumor diagnostics and follow-up with novel magnetic
resonance imaging methods: A single center study protocol.
PLoS
One. 2025 Nov 14;20(11):e0336387. doi:
10.1371/journal.pone.0336387. PMID:
41237103. Interventional study protocol. ˍ
Santos MDC, Rodrigues NMV, Gibram F, Brunelli J, Campos ACP,
Mancini A, Feher O, Marta GN, Hanna SA, Chung C, Moraes FY,
Maldaun MVC.
Wallerian degeneration of
the corticospinal tract following multimodal high-grade glioma
treatment: a case series and recommendations for radiotherapy
planning.
Front
Oncol. 2025 Nov 14;15:1605190. doi:
10.3389/fonc.2025.1605190. PMID:
41323381. Observational study. ˍ
Silver DJ, Poplawski GHD, Lathia JD.
Opposing
Functions of White Matter in Glioblastoma.
Neuro
Oncol. 2025 Nov 14:noaf266. doi:
10.1093/neuonc/noaf266. PMID:
41234043. Editorial. ˍ
Zhang W, Lin L, Li Y, Wang Y, Shen H, Guan Y.
Glioblastoma
with cerebrospinal fluid dissemination and MYC gene amplification:
A transitional or atypical glioblastoma with primitive neuronal
components.
Medicine
(Baltimore). 2025 Nov 14;104(46):e44072. doi:
10.1097/MD.0000000000044072. PMID:
41239669. Case report. ˍ
Al Qudah H, D Hamilton J, A Gubbiotti M, Msherghi A, Salim HA,
Alizada S, Liu HL, Kumar VA, Wintermark M, Eldaya RW.
Imaging
features of high-grade astrocytoma with piloid features: A single
center case series.
Neuroradiol
J. 2025 Nov 15:19714009251395689. doi:
10.1177/19714009251395689. PMID:
41239912. Observational study. ˍ
Faison SL, Batonga J, Arumugham T, Bartkus A, Morrison ME, Mullin
MJ, Tippin T, Naderer O.
A Phase 1
Study to Assess the Effect of Hepatic Impairment on the
Pharmacokinetics, Safety, and Tolerability of Dordaviprone.
J
Clin Pharmacol. 2025 Nov 15. doi:
10.1002/jcph.70129. PMID:
41239907. Interventional
study˰ ˍ
Mata-Mbemba D, Trasolini A, Maianski I, McFadden K, Crowell C,
Moineddin R, Sargent M, Cheng S, Perreault S, Erker C.
Molecular
subtype prediction model for pediatric low-grade gliomas using
conventional neuroradiology reporting.
Childs
Nerv Syst. 2025 Nov 15;41(1):355. doi:
10.1007/s00381-025-07024-8. PMID:
41240147. Observational
study˰ ˍ
Wach J, Weber F, Wende T, Vychopen M, Barrantes-Freer A, Pfahl A,
Köhler H, Güresir E.
GLIMMER:
an interim subgroup analysis from an ongoing prospective study
evaluating hyperspectral imaging for MGMT promoter methylation in
gliomas.
J
Neurooncol. 2025 Nov 17;176(1):86. doi:
10.1007/s11060-025-05340-2. PMID:
41247617. Interventional study.
ˍ
Weiner S, Warmuth-Metz M, Kandels D, Timmermann B, Kortmann RD,
Dietzsch S, Pietsch T, Bison B, Pham M, Gnekow AK, Quenzer A.
Decreased T2-signal intensities
indicate positive response to front-line radiotherapy in pediatric
low-grade gliomas.
Radiol
Med. 2025 Nov 17. doi:
10.1007/s11547-025-02118-4. PMID:
41247651. Observational study. ˍ
Yang Z, Tunje RC, Xia J, Sun C.
*Designing
a web-based platform for dynamic estimation of individualized
conditional survival in grade 3 gliomas.
Discov
Oncol. 2025 Nov 17;16(1):2111. doi:
10.1007/s12672-025-03885-2. PMID:
41249681. Observational study. ˍ
Aprile M, Di Nunno V, Gatto L, Tosoni A, Balestrini D, Ramponi V,
Conti A, Maffei M, Battaglia S, Argento CM, Zuliani E, Bartolini
S, Margotti M, Gentilini F, Tallini G, Asioli S, Franceschi E.
How to predict progression-free
survival in patients with grade 2 IDH-mutated diffuse gliomas
after surgery: a long-term follow-up analysis.
Front
Oncol. 2025 Nov 18;15:1673285. doi:
10.3389/fonc.2025.1673285. PMID:
41341389. Observational study. ˍ
Kassubek R, Amend M, Niessen H, Schmitz B, Engelke J, Grübel
N, Weishaupt J, Haeusler KG, Kassubek J, Müller
HP.
Longitudinal Cerebral Structural,
Microstructural, and Functional Alterations After Brain Tumor
Surgery for Early Detection of Recurrent Tumors.
Biomedicines.
2025 Nov 18;13(11):2811. doi:
10.3390/biomedicines13112811. PMID:
41301904. Observational study. ˍ
Di Nardo F, Le Vourc'h F, Bleunven J, Pedreni M, Seizeur R, Saliou
V.
Awake surgery and music: Two
illustrative cases of frontal resection in
pianists.
Neurochirurgie.
2025 Nov 19;72(1):101753. doi:
10.1016/j.neuchi.2025.101753. PMID:
41271094. Case report. ˍ
Liu S, Liang R.
Risk stratification
for intracranial infection after high-grade gliomas surgery: a
nomogram development and validation study.
Front
Oncol. 2025 Nov 19;15:1697966. doi:
10.3389/fonc.2025.1697966. PMID:
41347088. Observational study. ˍ
Raghu A, Killar S, Cohen AL.
Effects
of temozolomide dosing on outcome in glioblastoma.
J
Neurooncol. 2025 Nov 19;176(1):89. doi:
10.1007/s11060-025-05324-2. PMID:
41258619. Observational study. ˍ
Mikic N, Lukacova S, Skjøth-Rasmussen J, Poulsen FR,
Hauerberg J, Laursen RJ, Ettrup KS, Møller S, Haslund CA,
Dahlrot RH, Cortnum SOS, Sindby AK, Von Oettingen G, Valentin JB,
Solheim O, Solheim TS, Sørensen JCH, Wong ET, Korshøj
AR.
Dose-enhanced versus standard
TTFields for first recurrence of glioblastoma: A randomized phase
2 clinical trial.
Neurooncol
Adv. 2025 Nov 20;7(1):vdaf245. doi:
10.1093/noajnl/vdaf245. PMID:
41473750. Interventional study. ˍ